Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

85 results

Le chômage temporaire est-il antidote au coronavirus?

L’ONEM a confirmé que les employeurs peuvent, dans certaines situations, mettre des travailleurs en chômage temporaire pour force majeure en raison du coronavirus.

Dutch national police service liable for unlawful granting of firearms permit

In a recent decision (ECLI:NL:HR:2019:1409), the Supreme Court has decided that the Dutch national police force is liable for damage suffered by victims of a shooting which took place in a shopping centre in 2011; an event that shocked the Netherlands.

Stibbe advises Wright Medical Group

Stibbe is advising Wright Medical Group on the offer from Stryker to acquire Wright Medical Group. 

Stibbe advises Aedifica

Stibbe advised Aedifica on its secondary share listing on Euronext Amsterdam. Trading started on 7 November 2019.

Aan de slag met de nieuwe Wet hergebruik van overheidsinformatie

Op 18 juli 2015 is de Wet hergebruik van overheidsinformatie (de "Who") in werking getreden. Burgers en bedrijven kunnen bij publieketaakinstellingen een verzoek indienen tot het verstrekken van overheidsinformatie.

Clémence Jonckheere

Junior Associate Brussels

Product counseling en intellectueel eigendom

In deze podcastaflevering van Stibbe Legal Insights spreken Femke van der Voort, gespecialiseerd in intellectueel eigendom, en Paul van der Hulst, mede-eigenaar en managing director van MoviĜo, over het beschermen van intellectuele eigendomsrechten.

Stibbe advises Aedifica

Stibbe has advised Aedifica on the acquisition and lease of a care residence to be constructed in Lelystad and the acquisition and lease of a recently completed care residence in Zwolle. 

Breaking news from the CJEU: no SPCs for new therapeutic applications

On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.

Stibbe advises leading pharmaceutical company

Stibbe assisted a leading pharmaceutical company in identifying the most cost-effective way to obtain in Belgium an improved pricing and reimbursement for new fixed-dose combination products composed of off-patent ingredients.

Stibbe advises Canon

Advising Canon in connection with their dispute with the State of the Netherlands on the procurement of framework contracts. Case won up to and including the Supreme Court.

Stibbe advises Mylan

Stibbe advises global pharmaceutical company Mylan on the merger control aspects of its USD 7.2 billion acquisition of Swedish drugmaker Meda.

Stibbe advises Aedifica

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on reaching agreement to acquire two new senior housing sites in Lochem and Rotterdam.

Stibbe advises Aedifica

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on the acquisition of a new senior housing site in Arnhem.

This is the second investment of Aedifica in The Netherlands. Aedifica has developed a portfolio of health

Stibbe advises Sonova Holding AG

Stibbe has advised Sonova Holding AG on its acquisition of AudioNova B.V. from HAL Investments. The value of AudioNova is EUR 830 million.

Stibbe advises Aedifica

Stibbe advises Aedifica, a Belgian listed company investing in health care real estate, on its acquisition of four senior housing sites in The Netherlands.

Stibbe represents Mylan

On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition

Stibbe advises Tornier

Stibbe advises Tornier N.V. on its merger with Wright Medical Group, Inc. in an all stock transaction with a combined equity value of approximately $3.3 billion.

Pagination

  • Previous page
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Next page
Reset filters
Date
Content type
  • Article (21)
  • Event (2)
  • Inside Stibbe (1)
  • Matter (42)
  • Podcast (1)
  • People (18)
Expertise
  • (-) Healthcare and Life Sciences (85)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (422)
  • Capital Markets (243)
  • Compliance, Sanctions and Risk (163)
  • Corporate and M&A (855)
  • Corporate Investigations (31)
  • Criminal Law and Enforcement (141)
  • Digital Economy (106)
  • Employment, Benefits and Pensions (407)
  • Energy, Industry and Climate (310)
  • Environment and Planning (870)
  • ESG & Sustainability (289)
  • EU and Competition Law (488)
  • Financial Regulation (167)
  • Infrastructure and Mobility (193)
  • Insurance (36)
  • Intellectual Property (117)
  • Investment Funds (136)
  • Litigation and Arbitration (421)
  • Privacy and Data Protection (202)
  • Private Equity (196)
  • Procurement Law (122)
  • Public Law (1170)
  • Real Estate (466)
  • Restructuring and Insolvency (115)
  • Sports (25)
  • Stibbe StartsUP (29)
  • Tax (438)
  • Technology, Media and Telecommunications (327)
  • Unfair Competition and Consumer Protection (186)
Jurisdiction
  • BE Law (23)
  • EU Law (13)
  • LU Law (7)
  • NL Law (44)
Language
  • Dutch (9)
  • English (74)
  • French (2)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information